Bullock Wealth Management Group »

Outlook Therapeutics shares owned by Bullock Wealth Management Group

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Bullock Wealth Management Group from 13F filings

Historical chart of Bullock Wealth Management Group investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Bullock Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Bullock Wealth Management Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $339 1.6k 0.21
2025-12-31 $7.5k 4.8k 1.58

More positions owned by Bullock Wealth Management Group

Pacer Trendpilot Us Large Cap Etf Etf (PTLC)
Nvidia Corporation Stock (NVDA)
Pacer Trendpilot 100 Etf Etf (PTNQ)
Pacer Trendpilot International Etf Etf (PTIN)
Pacer Trendpilot Us Mid Cap Etf Etf (PTMC)
Microsoft Corp Stock (MSFT)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
Apple Stock (AAPL)
Eli Lilly & Co Stock (LLY)
Invesco S&p 500 Equal Weight Technology Etf Etf (RSPT)
Dimensional Ultrashort Fixed Income Etf Etf (DUSB)
Caterpillar Stock (CAT)
State Street Communication Services Select Sector Spdr Etf Etf (XLC)
Broadcom Stock (AVGO)
Jpmorgan Chase & Co Stock (JPM)

View all positions for Bullock Wealth Management Group

Top funds holding Outlook Therapeutics

Vanguard Capital Management
Perceptive Advisors
Marshall Wace
Susquehanna International
BlackRock
Jane Street
Geode Capital Management
Hrt Financial
Vanguard Fiduciary Trust
Gilpin Wealth Management
Citadel Advisors
Sanctuary Advisors
Raymond James Financial
Group One Trading
Northern Trust

View all funds holding Outlook Therapeutics